See All Slides - tctmd.com

Slides

Presentation TCT 2015

Stroke After TAVR 2: Controversy 1 Need for Cerebral Protection (Universal vs Selective)

Presenter: Samir R. Kapadia, Nicolas M. Van Mieghem

October 15, 2015

Presentation TCT 2015

Convince Me in 5 Minutes or Less That: Intravenous and Not Oral Hydration Is the Cornerstone for Contrast Nephropathy Prevention!

Presenter: Somjot S. Brar, Richard Solomon

October 15, 2015

Presentation TCT 2015

EVAR Treatment of Ruptured AAA: Current Review and Recommendations

Presenter: Jacques Busquet, Christopher K. Zarins, Clifford J. Buckley

October 15, 2015

Presentation TCT 2015

Paravalvular Regurgitation After TAVR 2: Importance of Valve Sizing and Calcium Patterns to Predict and Prevent Paravalvular Regurgitation After TAVR

Presenter: Samir R. Kapadia, Nicolas M. Van Mieghem, Jeffrey J. Popma

October 15, 2015

Presentation TCT 2015

Early Discharge After TAVR: The Vancouver Clinical Pathway, Including the North America 3M Study

Presenter: Ganesh Manoharan, Mathew Williams, Danny Dvir

October 15, 2015

Presentation TCT 2015

Hybrid Interventions on the Pulmonary Outflow Track in the Adult Patient

Presenter: John P. Cheatham, Lars Sondergaard, Damien P. Kenny

October 15, 2015

Presentation CICT 2015

TAVR The Edwards Sapien Valve: Evidence Update 2014-2015

Presenter: E Murat Tuzcu

August 01, 2015

Presentation TCT 2013

Bioresorbable Vascular Scaffolds and Drug-Eluting Balloons: Which Subsets Meaningfully Benefit Beyond Metallic DES?

Presenter: Patrick Serruys

October 31, 2013

Presentation TCT 2013

IA Treatment: Where Do We Stand Now? Including Analysis of Recent Negative Trials

Presenter: Philip Meyers

October 31, 2013

Presentation TCT 2013

BVS Follow-up Using Multiple Imaging Modalities: Research Implications vs. Clinical Utility

Presenter: Yoshinobu Onuma

October 31, 2013

Advertisement

Slides

Stroke After TAVR 2: Controversy 1 Need for Cerebral Protection (Universal vs Selective)

Convince Me in 5 Minutes or Less That: Intravenous and Not Oral Hydration Is the Cornerstone for Contrast Nephropathy Prevention!

EVAR Treatment of Ruptured AAA: Current Review and Recommendations

Paravalvular Regurgitation After TAVR 2: Importance of Valve Sizing and Calcium Patterns to Predict and Prevent Paravalvular Regurgitation After TAVR

Early Discharge After TAVR: The Vancouver Clinical Pathway, Including the North America 3M Study

Hybrid Interventions on the Pulmonary Outflow Track in the Adult Patient

TAVR The Edwards Sapien Valve: Evidence Update 2014-2015

Bioresorbable Vascular Scaffolds and Drug-Eluting Balloons: Which Subsets Meaningfully Benefit Beyond Metallic DES?

IA Treatment: Where Do We Stand Now? Including Analysis of Recent Negative Trials

BVS Follow-up Using Multiple Imaging Modalities: Research Implications vs. Clinical Utility

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content